Hyperthermia as an adjunctive treatment for soft-tissue sarcoma
Elisabetta Pennacchioli1, Marco Fiore, Alessandro Gronchi
1Melanoma Sarcoma Unit, Department of Surgery, Istituto Nazionale Tumori, Milan, Italy.
Expert Review of Anticancer Therapy
|February 6, 2009
Summary
Treating high-risk soft-tissue sarcomas (STSs) is challenging. Combining hyperthermia with chemotherapy enhances treatment efficacy by increasing tumor cell death and potentially modulating the immune system.
Area of Science:
- Oncology
- Medical Physics
Background:
- High-risk soft-tissue sarcomas (STSs) present a significant treatment challenge due to their propensity for hematogenous spread.
- Multimodality treatment, including surgery, radiochemotherapy, and increasingly hyperthermia, is crucial for managing STSs.
- Current research focuses on preoperative strategies to control systemic disease and reduce tumor size.
Purpose of the Study:
- To explore the role and rationale of hyperthermia in multimodal treatment strategies for adult high-risk soft-tissue sarcomas.
- To investigate the synergistic effects of combining hyperthermia with chemotherapy in STS treatment.
Main Methods:
- Review of existing literature and clinical evidence on hyperthermia application in STS treatment.
- Focus on hyperthermia in the 40-43°C range, combined with chemotherapy (alkylating agents, platinum analogs).
- Exploration of hyperthermia's role in neoadjuvant, adjuvant, and locoregional treatment settings.
Main Results:
- Hyperthermia, at clinically relevant temperatures (40-43°C), enhances the efficacy of chemotherapy through direct thermal toxicity and increased drug effectiveness.
- Hyperthermia may modulate the immune system by inducing heat-shock proteins, potentially improving treatment outcomes.
- Synergistic effects are observed in both systemic (preoperative/postoperative) and locoregional (isolated limb perfusion) applications.
Conclusions:
- Hyperthermia is a valuable component of multimodal therapy for high-risk STSs, enhancing chemotherapy's effectiveness.
- The combination of hyperthermia and chemotherapy offers a promising strategy for improving local control and managing systemic disease in STS.
- Further research into hyperthermia's immunomodulatory effects could lead to novel therapeutic approaches for STS.
Related Concept Videos
01:25Increased Body Temperature
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in response to an infection or illness.
01:29Decreased Body Temperature
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
01:19Homeostatic Imbalances in Body Temperature
Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...